These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27175625)

  • 1. Deciphering the effect of an oxovanadium(iv) complex with the flavonoid chrysin (VOChrys) on intracellular cell signalling pathways in an osteosarcoma cell line.
    León IE; Díez P; Etcheverry SB; Fuentes M
    Metallomics; 2016 Aug; 8(8):739-49. PubMed ID: 27175625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor properties of a vanadyl(IV) complex with the flavonoid chrysin [VO(chrysin)2EtOH]2 in a human osteosarcoma model: the role of oxidative stress and apoptosis.
    Leon IE; Di Virgilio AL; Porro V; Muglia CI; Naso LG; Williams PA; Bollati-Fogolin M; Etcheverry SB
    Dalton Trans; 2013 Sep; 42(33):11868-80. PubMed ID: 23760674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoding the anticancer activity of VO-clioquinol compound: the mechanism of action and cell death pathways in human osteosarcoma cells.
    León IE; Díez P; Baran EJ; Etcheverry SB; Fuentes M
    Metallomics; 2017 Jul; 9(7):891-901. PubMed ID: 28581009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo antitumor effects of the VO-chrysin complex on a new three-dimensional osteosarcoma spheroids model and a xenograft tumor in mice.
    León IE; Cadavid-Vargas JF; Resasco A; Maschi F; Ayala MA; Carbone C; Etcheverry SB
    J Biol Inorg Chem; 2016 Dec; 21(8):1009-1020. PubMed ID: 27696106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidovanadium(IV) complexes with chrysin and silibinin: anticancer activity and mechanisms of action in a human colon adenocarcinoma model.
    León IE; Cadavid-Vargas JF; Tiscornia I; Porro V; Castelli S; Katkar P; Desideri A; Bollati-Fogolin M; Etcheverry SB
    J Biol Inorg Chem; 2015 Oct; 20(7):1175-91. PubMed ID: 26404080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of oxidative stress in the antitumoral action of a new vanadyl(IV) complex with the flavonoid chrysin in two osteoblast cell lines: relationship with the radical scavenger activity.
    Naso L; Ferrer EG; Lezama L; Rojo T; Etcheverry SB; Williams P
    J Biol Inorg Chem; 2010 Aug; 15(6):889-902. PubMed ID: 20364393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent.
    Narla RK; Dong Y; D'Cruz OJ; Navara C; Uckun FM
    Clin Cancer Res; 2000 Apr; 6(4):1546-56. PubMed ID: 10778988
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Balsa LM; Quispe P; Baran EJ; Lavecchia MJ; León IE
    Metallomics; 2020 Dec; 12(12):1931-1940. PubMed ID: 33107537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new oxidovanadium(IV) complex of oxodiacetic acid and dppz: spectroscopic and DFT study. Antitumor action on MG-63 human osteosarcoma cell line.
    León IE; Parajón-Costa BS; Franca CA; Etcheverry SB; Baran EJ
    Biol Trace Elem Res; 2015 Apr; 164(2):198-204. PubMed ID: 25534289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmanicidal activity of polysaccharides and their oxovanadium(IV/V) complexes.
    do Amaral AE; Petkowicz CL; Mercê AL; Iacomini M; Martinez GR; Merlin Rocha ME; Cadena SM; Noleto GR
    Eur J Med Chem; 2015 Jan; 90():732-41. PubMed ID: 25506811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative and apoptosis-inducing activity of an oxidovanadium(IV) complex with the flavonoid silibinin against osteosarcoma cells.
    Leon IE; Porro V; Di Virgilio AL; Naso LG; Williams PA; Bollati-Fogolín M; Etcheverry SB
    J Biol Inorg Chem; 2014 Jan; 19(1):59-74. PubMed ID: 24233155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper(II) Complexes with Saccharinate and Glutamine as Antitumor Agents: Cytoand Genotoxicity in Human Osteosarcoma Cells.
    Cadavid-Vargas JF; Leon IE; Etcheverry SB; Santi E; Torre MH; Di Virgilio AL
    Anticancer Agents Med Chem; 2017; 17(3):424-433. PubMed ID: 27173967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxylamido-amino acid complexes of oxovanadium(V). Toxicological study in cell culture and in a zebrafish model.
    León IE; Di Virgilio AL; Barrio DA; Arrambide G; Gambino D; Etcheverry SB
    Metallomics; 2012 Dec; 4(12):1287-96. PubMed ID: 23073485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant, DNA cleavage, and cellular effects of silibinin and a new oxovanadium(IV)/silibinin complex.
    Naso LG; Ferrer EG; Butenko N; Cavaco I; Lezama L; Rojo T; Etcheverry SB; Williams PA
    J Biol Inorg Chem; 2011 Apr; 16(4):653-68. PubMed ID: 21399988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of xyloglucan from Copaifera langsdorffii and its complex with oxovanadium (IV/V) on B16F10 cells.
    Farias CLA; Martinez GR; Cadena SMSC; Mercê ALR; de Oliveira Petkowicz CL; Noleto GR
    Int J Biol Macromol; 2019 Jan; 121():1019-1028. PubMed ID: 30340004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-parvifuran inhibits metastatic and invasive actions through the JAK2/STAT3 pathway in osteosarcoma cells.
    Yun HM; Park KR; Quang TH; Oh H; Hong JT; Kim YC; Kim EC
    Arch Pharm Res; 2017 May; 40(5):601-609. PubMed ID: 28386742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavonoids Active Against Osteosarcoma: A Review of the Molecular Mechanisms Involved.
    Liu H; Gao Y; Dong Y; Cheng P; Chen A; Huang H
    Curr Pharm Des; 2017; 23(13):1993-2001. PubMed ID: 28201973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectroscopic characterization of an oxovanadium(IV) complex of oxodiacetic acid and o-phenanthroline. Bioactivity on osteoblast-like cells in culture.
    León IE; Etcheverry SB; Parajón-Costa BS; Baran EJ
    Biol Trace Elem Res; 2012 Jun; 147(1-3):403-7. PubMed ID: 22246791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyoxometalates as antitumor agents: Bioactivity of a new polyoxometalate with copper on a human osteosarcoma model.
    León IE; Porro V; Astrada S; Egusquiza MG; Cabello CI; Bollati-Fogolin M; Etcheverry SB
    Chem Biol Interact; 2014 Oct; 222():87-96. PubMed ID: 25451568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronate blocks geranylgeranylation not farnesylation to suppress human osteosarcoma U2OS cells metastasis by EMT via Rho A activation and FAK-inhibited JNK and p38 pathways.
    Cheng HL; Lin CW; Yang JS; Hsieh MJ; Yang SF; Lu KH
    Oncotarget; 2016 Mar; 7(9):9742-58. PubMed ID: 26848867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.